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Intercellular communications control fundamental biological processes required for the
survival of multicellular organisms. Secretory proteins are among the most important mes-
sengers in this network of information. Proteins destined to the extracellular environment
contain a signal sequence with the necessary information to target them to the Endoplas-
mic Reticulum, and are released by a “classical” pathway of secretion. However, in the
early 1990s it became evident that non-classical mechanisms must exist for the secretion
of some proteins, which in spite of their extracellular localization and function, lack a signal
peptide. Indeed, the group of leaderless secretory proteins rapidly grew and is still growing.
Many of them are implicated in the regulation of the inflammatory response. Interestingly,
most members of the IL-1 family (IL-1F), including the master pro-inflammatory cytokine
IL-1β, are leaderless proteins and find their way out of the cells in different manners. In this
article, we will review current hypotheses on the mechanisms of externalization of IL-1F
members and discuss their relevance with respect to the different functions (as cytokines
or as DAMPs) played by the different IL-1 proteins.
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THE IL-1 FAMILY
IL-1 family (IL-1F) is evolutionary ancient. Eleven IL-1 members
have been identified (Table 1) based on conservation of amino
acid sequence, identity of gene structure, and three-dimensional
structure (Dunn et al., 2001). Most of them (with the exception
of IL-18 and IL-33, Nolan et al., 1998; Schmitz et al., 2005) map
to chromosome 2 between the IL-1α and IL-1 Receptor antago-
nist (IL-1ra) loci (Nicklin et al., 2002), suggesting that each IL-1F
member derives from the duplication of a common ancestral gene.
Each IL-1 gene codes for a protein that contains a single struc-
tural domain formed from 12 beta strands connected by loop
regions arranged in a beta-trefoil structure. IL-1F members dif-
fer most from each other within these loop regions (Dunn et al.,
2001).
The various members of the IL-1F play different biologic activ-
ities all involved in innate immunity (Dinarello, 2009). Interest-
ingly, although most IL-1F proteins are proinflammatory, also
members endowed with anti-inflammatory properties exist, the
most important being IL-1ra (Arend et al., 1998).
Most IL-1 family members share features which make them dif-
ferent from the other cytokines. First of all, they are synthesized as
precursor proteins that subsequently undergo proteolytic matu-
ration by converting enzymes. Proteolytic maturation is strictly
required for activation of some members of IL-1 family, such
as IL-1β, IL-18 (Dinarello, 1998a), and IL-37 (Boraschi et al.,
2011). In the case of other IL-1F members, the precursor is
able to engage its receptor and trigger a response on target cells.
This is the case of IL-1α (Dinarello, 1998b) and IL-33 (Mous-
sion et al., 2008). The major converting enzyme responsible for
processing of IL-1β, IL-18, and IL-37 is caspase-1 (Black et al.,
1988; Ghayur et al., 1997; Kumar et al., 2002). This convertase
is produced as a zymogen (pro-caspase-1) and undergoes activa-
tion upon the assembly of intracellular multiprotein complexes
named inflammasomes (Bauernfeind et al., 2011). Different types
of Inflammasomes exist, each composed by a member of the
nucleotide-binding domain leucine-rich repeat containing (NLR)
gene family, adaptor proteins, and pro-caspase-1 molecules.
A second, important feature of IL-1F proteins is that only IL-
1ra is a classical secretory protein endowed with a signal peptide:
all the other members are leaderless (Dinarello, 2009).
LEADERLESS IL-1 CYTOKINES: HOW DO THEY GET OUT OF
CELLS?
In principle, leaderless proteins, synthesized in the soluble cytosol,
should stay there: a quite unlikely behavior for soluble mediators
of inflammation. Alternatively, they must find a way out different
from the classical secretory pathway. When the gene of IL-1β was
cloned revealing the absence of a signal sequence (Auron et al.,
1984) the first explanation for IL-1β externalization was that it
was simply released by cells dying at the site of inflammation.
This hypothesis was ruled out many years ago by two major evi-
dences (Muesch et al., 1990; Rubartelli et al., 1990): (i) IL-1β is
selectively released by LPS activated human monocytes: only the
mature form of IL-1β, but neither the IL-1β precursor (pro-IL-1β)
nor other cytosolic proteins are detectable in culture supernatants;
(ii) viable cells are required for secretion of mature IL-1β: when
activated monocytes were killed by freezing and thawing before
incubating at 37˚C, only pro-IL-1β accumulated in the culture
supernatant.
Further studies confirmed that an active secretory pathway,
different from the ER-Golgi one, exists for IL-1β and also for IL-
18 (Andrei et al., 1999; MacKenzie et al., 2001; Qu et al., 2007).
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Death as a mechanism of secretion was instead proposed for other
members of the IL-1F, such as IL-1α and confirmed by various
studies Sakurai et al. (2008), Luheshi et al. (2009), and Cohen
et al. (2010).
SECRETION OF IL-1β AND IL-18
Secretion of IL-1β and IL-18 needs two signals (Figure 1A). A first
signal, supplied by bacterial products that bind and activate Toll-
like Receptors (TLR), triggers IL-1β expression and synthesis; this
Table 1 | IL-1 family members.
Family name Name Receptor/coreceptor Property Synthesized as precursor Processing required for activity
IL-1F1 IL-1α IL-1RI/IL-1RacP Proinflammatory Yes No
IL-1F2 IL-1β IL-1RI/IL-1RacP Proinflammatory Yes Yes
IL-1F3 IL-1Ra IL-1RI Antagonist for IL-1α,β No No
IL-1F4 IL-18 IL-18Rα/IL-18Rβ Proinflammatory Yes Yes
IL-1F5 IL-36Ra IL-1Rrp2 Antagonist for IL-36 Yes Yes
IL-1F6 IL-36α IL-1Rrp2/IL-1RAcP Proinflammatory Yes Yes
IL-1F7 IL-37 IL-18Rα, IL18BP Anti-inflammatory Yes Yes
IL-1F8 IL-36β IL-1Rrp2/IL-1RAcP Proinflammatory Yes Yes
IL1-F9 IL-36γ IL-1Rrp2/IL-1RAcP Proinflammatory Yes Yes
IL-1F10 IL-38 IL-1Rrp2 ? Antagonist Yes ? No
IL-1F11 IL-33 ST2/IL-1RAcP Proinflammatory Yes No
FIGURE 1 | Lysosome exocytosis allows diffuse and polarized secretion
of IL-1β and IL-18. (A) Models of non-polarized secretion of IL-1β. TLR agonists
(e.g., PAMPs) induce monocytes/macrophages to actively synthesize pro-IL-1β
that accumulates into the cytosol and in part into secretory lysosomes. A
second extracellular soluble signal (e.g., ATP) triggers generalized lysosome
exocytosis (Andrei et al., 1999). A similar mechanism accounts for IL-18
secretion (Perregaux et al., 2000). (B) Models of polarized (lower panel)
secretion of IL-1β. In DCs, a first maturative stimulus (e.g., TLR triggering),
induces pro-IL-1β synthesis. The second signal is provided by antigen specific
T cells that induces a [Ca2+]i rise, followed by recruitment of IL-1β-containing
secretory lysosomes toward the interactingT cell, and by exocytosis restricted
to the intercellular space (immunological synapse) (Gardella et al., 2000b,
2001). A similar mechanism mediates IL-18 secretion in DCs interacting with
autologous NK cells (Semino et al., 2005). (C). Electron microscopy analysis
of a DC interacting with a NK cell. Interaction between the two cells occurs
primarily in correspondence with DC areas enriched by mitochondria and
vesicles (red arrows). The immunological synapse is indicated by the green
arrow. (D) Confocal microscopy analysis of tubulin (green) and IL-18 (red) in a
DC/NK conjugate after 3 h of interaction. The strong co-staining of IL-18 and
tubulin in both transversal and sagittal sections indicates that IL-18 from DC
polarizes toward the NK/DC synapse and is transported along tubulin
filaments. (C,D): modified from Semino and Rubartelli (2010).
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signal is needed also for IL-18 secretion even though IL-18 is con-
stitutively expressed by myeloid cells (Perregaux et al., 2000). The
second signal is provided by a variety of diverse stimuli: endoge-
nous, such as extracellular ATP, or exogenous, such as microbial
products or pathogenic crystals (Bauernfeind et al., 2011). How-
ever, while in murine macrophages a second signal is strictly
required, in primary human monocytes the addition of second
signals such as ATP strongly enhances secretion but is dispensable
as bacterial products alone are sufficient to induce secretion of IL-
1β, although at a lower extent and with slow kinetics (Piccini et al.,
2008). In fact upon TLR-triggering, human monocytes externalize
functionally effective amounts of their ATP that in turn stimulates
autocrinally the monocyte purinergic P2× 7 receptor, triggering
the cascade of events that lead to inflammasome activation and
IL-1β secretion (Piccini et al., 2008).
Several models of IL-1β and IL-18 secretion have been pro-
posed but the precise mechanism remains elusive. In particular,
where and how inflammasome activation and processing of the
two pro-cytokines occur, as well as the link between process-
ing and secretion are still unknown (Rubartelli, 2012). Most of
the described IL-1β secretory pathways involve the externaliza-
tion of the cytokine via vesicles (Andrei et al., 1999; MacKenzie
et al., 2001; Qu et al., 2007). Secretory lysosomes, microvesicles
shed from the plasma membrane, and exosomes have been iden-
tified as vesicles able to carry IL-1β out of the cell in different cell
types (primary monocytes, monocyte continuous cell lines, mouse
macrophages).
An additional, non-vesicular pathway of IL-1β secretion may
take place in monocyte/macrophages where sustained activation
of the NLRP3 or NLRC4 inflammasome cascade induces caspase-
1-mediated pyroptotic death (Le Feuvre et al., 2002; Brough and
Rothwell, 2007; Bergsbaken et al., 2009). In these cells, a direct
efflux of cytosolic mature IL-1β occurs across hyper-permeable
plasma membranes.
It is possible that differences in the cell type, in the functional
state of the cells or in the culture conditions, as well as strength
and duration of the stimulus (Carta et al., 2011; Lopez-Castejon
and Brough, 2011) may account for the different vesicular or
non-vesicular IL-1β secretory pathways used.
The first suggested mechanism is the secretory lysosome-
dependent pathway, characterized in our lab on primary human
monocytes (Andrei et al., 1999, 2004). In this model, pro-IL-1β
is translocated together with caspase-1 into vesicles belonging
to the endolysosomal compartment. The mature form of IL-
1β is produced within the vesicles by caspase-1 cleavage, after
which the endolysosomes fuse with the plasma membrane and
the content is released into the extracellular space. The capac-
ity to fuse with plasma membrane and to externalize the solu-
ble content is a peculiarity of a subset of endolysosomes, called
secretory lysosomes (Blott and Griffiths, 2002). These are Ca2+-
regulated secretory organelles displaying features of both classical
endolysosomes and secretory granules responsible for regulated
secretion in specialized cells (Blott and Griffiths, 2002). Partic-
ularly abundant in hemopoietic cells they participate in inflam-
matory and immune response by mobilizing their content into
the external milieu in response to triggering signals. For instance,
CTL and NK cells destroy their infected or tumor target cells
by secreting cytolytic proteins, which are stored in secretory
lysosomes.
Other leaderless proteins may be imported into cytoplasmic
organelles related to the lysosomal compartment in myelomono-
cytic cells. Among IL-1F members, IL-18 seems to follow the same
route as IL-1β (Semino et al., 2005). Also HMGB1, another inflam-
matory mediator, is present into endolysosomal related organelles
of activated monocytes (Gardella et al., 2002). Given the impli-
cation of secretory lysosomes in many immune-inflammatory
processes (Blott and Griffiths, 2002), lysosome-mediated secretion
of IL-1β, IL-18, HMGB1 is consistent with the role played by these
proteins in the modulation of innate immunity. Interestingly, the
involvement of acidic vesicles in the export of leaderless proteins
is evolutionary conserved as in Dictyostelium discoideum, translo-
cation into exocytic contractile vacuoles of DdCAD-1, a leaderless
adhesion protein, is necessary for its externalization (Sesaki et al.,
1997).
LYSOSOME-MEDIATED POLARIZED SECRETION
In general, lysosome-mediated secretion is a regulated process in
that a triggering signal is required to induce exocytosis (Blott and
Griffiths, 2002). In the case of IL-1β, we have shown that LPS
induce synthesis of pro-IL-1β with cytosolic accumulation and
lysosomal translocation, then exogenous ATP triggers with IL-
1β release (Andrei et al., 2004). A similar two step mechanism
seems to account for the regulated secretion of IL-18 (Perre-
gaux et al., 2000) and HMGB1 (Gardella et al., 2002). In all
these cases, the signal triggering secretion is generated during
the process of inflammation: ATP, promoting IL-1β and IL-18
secretion (Laliberte et al., 1997; Perregaux et al., 2000), is released
by monocytes themselves after TLR stimulation and by other
cells involved in inflammation (i.e., platelets) (Ferrari et al., 1997;
Piccini et al., 2008); differently, active phospholipids such as phos-
phatidylcholine, possible responsible for secretion of HMGB1,
appear later in the inflammatory microenvironment (Gardella
et al., 2002).
Interestingly, not only inflammatory cells such as monocytes
but also mature dendritic cells (DCs), the professional antigen
presenting cells, express inflammatory leaderless cytokines such
as IL-1β and IL-18. In these cells, secretion may be induced by
antigen specific T cells (Gardella et al., 1999, 2000a,b, 2001) or
NK cells (Semino et al., 2005). Morphological approaches allowed
to demonstrated that interaction between DCs and CD8+ T cells
(Gardella et al., 2001) or NK cells (Semino et al., 2005) is asso-
ciated with recruitment of IL-1β or IL-18-containing secretory
lysosomes in the area of contact among the cells followed by
polarization of these organelles, with evidence of lysosome exo-
cytosis at the intercellular space, the so called “immunological
synapse” (Figures 1B–D). These findings deserve two consid-
erations. On the one hand, they underline the existence of a
bidirectional cross talk between DCs and T lymphocytes or NK
cell specifically interacting with them, in which the T or the
NK cell induce the functional polarization of the DC and the
DC responds by degranulation oriented toward the same inter-
acting T or NK cell, with obvious relevance for the control of
the immune response. On the other hand, the different way of
regulating secretion by monocytes and DCs may account for
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the different function of IL-1β and IL-18 in inflammation and
immune response (Figure 1). Monocytes respond to soluble sig-
nals with generalized exocytosis, thus allowing the spreading of
inflammatory cytokines in the microenvironment (Figure 1A).
DCs respond to the localized signal provided by the interacting
T or NK cell (Figures 1B–D). This restricts the area of release to
the immunological synapse and allows activation of target cells
without spreading of the cytokine, thus controlling inflammation.
Thus, lysosome-mediated secretion of inflammatory leaderless
proteins allows polarized secretion in non-polarized cells (Chimini
and Rubartelli, 2005).
AUTOPHAGY AND IL-1β AND IL-18 SECRETION: LYSOSOME
EXOCYTOSIS REVISITED?
Autophagy preserves the correct quality and quantity of the
eukaryotic cytoplasm through two main highly conserved mecha-
nisms: (i) cytosol autodigestion during starvation, which ensures
cell-autonomous provision of energy and nutrients; (ii) removal
of old organelles and aggregates exceeding the capacity of other
cellular degradative systems (Levine and Kroemer, 2008). Recently,
an involvement of autophagy in the process of leaderless secretion
has been proposed. In fact, the secretion of the yeast leaderless
secretory protein Acb1 was strongly enhanced by treatments that
induce autophagy (nitrogen starvation or rapamycin). Accord-
ingly, strains mutant for different key factors of autophagy are
deficient in Acb1 secretion (Duran et al., 2010; Manjithaya et al.,
2010). These results suggest that Acb1 is sequestered in autophago-
somes that do not fuse with the vacuole but with endosomes to
form amphisomes. Amphisomes might, in turn, fuse with the
plasma membrane leading to Acb1 release in the extracellular
medium (Giuliani et al., 2011). In agreement with the data on
yeast, a link between autophagy and secretion of IL-1β is being
emerging. In principle, the “secretory lysosomes” that were for-
merly found to containing IL-1β and caspase-1 may well repre-
sent autophagosomes, and like autophagosomes, may be destined
either to fusion with lysosomes, and thereby to autophagic degra-
dation of their cargoes, or to fusion with the plasma membrane,
with externalization of their cargoes (Figure 2).
However, how autophagy regulates IL-1β secretion is highly
debated. Both articles suggesting that autophagy inhibits secre-
tion (Saitoh et al., 2008; Crisan et al., 2011; Harris et al., 2011;
Zhou et al., 2011; Shi et al., 2012) and viceversa, that autophagy
is required for IL-1β secretion (Dupont et al., 2011) have been
published.
The hypothesis of autophagy as a positive mediator of IL-1β
secretion is more appealing, according to the following consider-
ations: (i) TLR triggering, a crucial step in IL-1β secretion, which
is both necessary and sufficient to drive IL-1β synthesis, matu-
ration, and secretion in human monocytes (Piccini et al., 2008),
induces autophagy in myelomonocytic cells (Xu et al., 2007; Del-
gado et al., 2008); (ii) the hypothesis is consistent with the vesicular
models of IL-1β secretion (Andrei et al., 1999; Qu et al., 2007).
Besides, autophagy as a blocking mechanism for IL-1β secretion
is supported by clear in vitro data, such as the strong inhibition
of IL-1β secretion induced by substances that promote autophagy
and, conversely, the enhancement observed with compounds that
FIGURE 2 | Model of autophagosome involvement in IL-1β
secretion. Cytosolic pro-IL-1β is sequestered in part into vesicles
belonging to the autophagosomal-lysosomal compartment
(autophagosomes?). Autophagosomes may then fuse either with
lysosomes (Ly), resulting in degradation of pro-IL-1β, or with
endosomes (E) to form amphisomes, were pro-IL-1β may undergo
processing. Amphisomes then fuse with the plasma membrane
leading to exocytosis of IL-1β. Type and strength of the stimuli may
determine the fusion with either endosomes or lysosomes, and thus
dictate the fate of pro-IL-1β toward degradation or secretion. Support to
this hypothesis comes from the observation that the vacuolar H+
ATPase inhibitor bafilomycin A1 (BafA1) that prevents the fusion
between autophagosomes and lysosomes, promotes IL-1β secretion
(Sonia Carta and Anna Rubartelli, unpublished results).
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block autophagy (Crisan et al., 2011; Harris et al., 2011; Shi et al.,
2012) and by the results obtained in mice deficient of autophagy
genes (Saitoh et al., 2008; Nakahira et al., 2011).
A possible explanation for these contrasting findings is that
formation of pro-IL-1β containing autophagosomes is a pre-
requisite for IL-1β secretion, and it is induced by TLR activation.
Autophagosomes may then undergo exocytosis, with secretion
of IL-1β, or fuse to lysosomes, with degradation of pro-IL-1β,
depending on the type and strength of the stimuli that trigger IL-
1β producing cells. Thus, strong stimuli (e.g., high doses of TLR
agonists) or exposure to inducer of autophagy such as rapamycin,
would privilege maturation of autophagosome to autolysosome,
and degradation of its content by the hydrolases provided by lyso-
somes. Weaker stimuli, such as continuous triggering by lower
doses of TLR agonists would instead favor amphisome fusion with
the plasma membrane, resulting in secretion (Figure 2).
THE TRAVEL OF CYTOKINES FROM INSIDE TO OUTSIDE
DURING EVOLUTION. BOTH PASSIVE RELEASE AND ACTIVE
SECRETION ACCOUNT FOR IL-1α AND IL-33
EXTERNALIZATION
The founding member of IL-1 family is probably IL-1α because of
its close homology to acidic FGF, in turn one of the most ancient
cytokines. It is conceivable that, at the beginning, IL-1F cytokines
were, like FGF, intracellular growth factors, and repair molecules
interacting with DNA as transcription factors (Dinarello, 2010)
and were passively externalized by dying cells. When later in evolu-
tion Immunoglobulins appeared, they were used by extracellular
cytokines/growth factors as cell surface receptors, and cytokine-
mediated signaling evolved. Some IL-1F members including IL-1α
and IL-33 retain intracellular (nuclear) function (Carriere et al.,
2007; Cayrol and Girard, 2009). Interestingly, unlike IL-1β and IL-
18, IL-1α, and IL-33 can activate their receptors on target cells as
full-length molecules: thus when released from injured cells they
can exert their biological activity in the absence of a proteolytic
processing (Chen et al., 2007; Eigenbrod et al., 2008; Cayrol and
Girard, 2009).
Based on the above observations, IL-1 family members can be
divided into a group of cytokines that retain some intracellular
function and are passively externalized upon cell lysis (the proto-
type being IL-1α), and a second group including cytokines that are
stored into the cell cytosol before secretion, but do not play intra-
cellular function and undergo regulated processing and secretion
(the prototype being IL-1β).
Still, the situation is more complex. In fact, a number of reports
indicate the possibility that also IL-1α and IL-33 are actively
released by cells that maintain their integrity. IL-1αwas reported to
be secreted in response to heat shock (Mandinova et al., 2003) and
through an unknown mechanism requiring caspase-1 (Gross et al.,
2012). In the case of IL-33, intracellular calcium increase, regulated
autocrinally by ATP and purinergic receptor stimulation, induces
translocation from nucleus to cytoplasm and release of full-length
IL-33 (Kouzaki et al., 2011). Extracellular ATP is a well-known
inducer of inflammasome activation and IL-1β/IL-18 processing.
The mechanism through which ATP induces IL-33 secretion seems
to be different, since the unprocessed, full-length molecular form
of IL-33 is secreted. However, we have previously observed that
in human monocytes ATP drives exocytosis of pro-IL-1β contain-
ing vesicles also if caspase-1 is inhibited, resulting in secretion of
the precursor form of the cytokine (Andrei et al., 2004). Moreover,
both in monocytes and in DCs, calcium influx induces secretion of
pro-IL-1β and pro-IL-18 (Gardella et al., 2000a, 2001; Andrei et al.,
2004). Thus it is conceivable that the pathway described for IL-33
makes use of mechanisms (purinergic receptor stimulation and
calcium influx) which are old and conserved during evolution. The
ATP-mediated signaling may then have further specialized adding
to the older function of inducing exocytosis the newer function
of controlling inflammasome activation and hence bioactivity of
cytokines such as IL-1β and IL-18.
Although the study by Kouzaki et al. (2011) did not investigate
the subcellular localization of IL-33 after its nucleus-cytoplasmic
translocation in airway epithelial cells, a recent report (Kakkar
et al., 2012) indicates that, in fibroblasts, newly synthesized IL-33
first moves to the nucleus and then is translocated to cytoplas-
mic vesicles, a pathway reminiscent of that followed by HMGB1
(Gardella et al., 2002). Secretion of uncleaved IL-33 is induced by
mechanical strain (i.e., application of a physical deformation) in
the absence of cellular necrosis (Kakkar et al., 2012). Extracellu-
lar release of IL-33 is also observed in mice subjected to acute
transaortic constriction, which causes mechanical stress in the
left ventricle (Kakkar et al., 2012). Together, these data suggest
that IL-1α and IL-33 may be secreted by cells that are subjected
to non-lethal stress in addition of being released by necrotic
cells.
EVOLUTION OF LEADERLESS SECRETION
Mechanisms of secretion of leaderless proteins were probably
exploited by cells to get rid of proteins which can be harmful,
either because they are misfolded, or too abundant, or mislo-
cated. Such mechanisms exists in yeast, where toxic proteins are
removed from the cytoplasm through a non-classical mechanism
of secretion (Cleves et al., 1996). A similar mechanism operates
also in mammals: for instance, the sulfotransferase rhodanese,
which in physiological conditions accumulates in mitochondria,
when overexpressed is rapidly externalized by transfected cells
without any sign of cell lysis (Sloan et al., 1994). Similarly,
expression of Green Fluorescent Protein (GFP) results in cytoso-
lic accumulation of properly folded protein but also activates
the secretion of misfolded GFP molecules (Tanudji et al., 2002).
Leaderless secretion may thus act as a safety valve, maintaining
cellular homeostasis when the cytoplasmic degradative pathways
are overloaded.
STRESS AS A COMMON INDUCER OF IL-1F MEMBER
LEADERLESS SECRETION
As discussed above the various members of the IL-1 family have
exploited many different ways to get out of cells. However, all of
them seem to be switched on by cellular stress due to changes
in environmental conditions (Giuliani et al., 2011). This is true
both for the passive release by dying cells exploited by IL-1α
and IL-33, since death represents the last step of a cell subjected
to stress, and for the more complex secretion of IL-1β and IL-
18 that are regulated by redox stress (Cruz et al., 2007; Dostert
et al., 2008; Hewinson et al., 2008; Meissner et al., 2008; Tassi
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et al., 2009). Interestingly, both purinergic receptor stimulation
and mechanical stress, cause a disturbance of redox homeosta-
sis resulting in redox response (Wu et al., 2013); redox response
is also required for inflammasome activation (Rubartelli, 2012).
Interestingly, a recent study shows that mechanical stress, which as
stated above induces IL-33 secretion, is sensed by NLRP3 inflam-
masome and leads to IL-1β processing and secretion (Wu et al.,
2013). Mechanical stretch induces production of Reactive Oxy-
gen Species (ROS) which are well-known players in the mecha-
nism of NLRP3 inflammasome activation (Rubartelli, 2012). ROS
production is also a very ancient cell defense mechanism (Navi-
aux, 2012) and induce redox signaling (Carta et al., 2009). It
is possible that, depending on the cell type, the redox signal-
ing is different, resulting in different effects on cytokine pro-
cessing/release. For instance, while in professional inflammatory
cells the evolution of the inflammasome complex favors redox-
mediated processing of IL-1β and IL-18, in airway epithelial cells
or fibroblasts the redox response could only induce cytokine
externalization.
Stress as an inducer of secretion of many IL-1 family members
is in agreement with the fact that the interleukin (IL)-1 fam-
ily more than any other cytokine family is closely linked to the
innate immune response, that is, to the first line of host defense
against stressful noxia (Dinarello, 2009). This link became evi-
dent upon the discovery that the cytoplasmic domain of the IL-1
receptor type I is highly homologous to the cytoplasmic domains
of all TLRs (Medzhitov et al., 1997). Fundamental inflamma-
tory responses such as the induction of cyclooxygenase type 2,
increased expression of adhesion molecules, or synthesis of nitric
oxide are indistinguishable responses of both IL-1 and TLR lig-
ands (Dinarello, 2009). Thus, IL-1F members are a “frontline”
emergency cytokines produced very early in response to multiple
stresses.
IL-1F MEMBERS: BORDERLINE BETWEEN DAMPs AND
CYTOKINES
Another group of early inducers of inflammation are DAMPs.
These are usually nuclear or cytosolic proteins, with a defined
intracellular function that, when released by stressed cells under-
going necrosis, act as endogenous danger signals and initiate
and perpetuate inflammation (Lotze et al., 2007). This is pos-
sible because DAMPs binds to specific receptors, unrelated to
their intracellular function, whose engagement triggers inflam-
matory responses on target cells. The DAMPs features listed
above are very similar to those associated to some IL-1F mem-
bers, particularly IL-1α and IL-33. In fact, unlike IL-1β which
is induced in a restricted number of inflammatory cells by
inflammatory stimuli and undergoes regulated secretion, IL-1α
and IL-33 are constitutively expressed and accumulate in large
amounts in “barrier tissues” (epithelial and endothelial), the first
ones entering in contact with external noxia (Dinarello, 2009;
Liew et al., 2010). Both IL-1α and IL-33, although constitu-
tively expressed, are further induced by stress conditions, thus
increasing the amount of inflammatory mediator ready to be
released in case of need. Interestingly, also certain DAMPs, such
as HMGB1 are further increased in cells exposed to stress (Lotze
et al., 2007).
The difference between cytokines such as IL-1α and IL-33 and
DAMPs is therefore a moot point. The argument that DAMPs are
only released by dying cells, whereas IL-1α and IL-33 can also be
actively secreted has been discarded by the demonstration that
the DAMP HMGB1 undergoes regulated secretion by certain cell
types (Gardella et al., 2002). Actually, more recent data indicate
that secretion of HMGB1, as well as of other leaderless secretory
proteins not belonging to IL-1F, is also dependent on caspase-1
and inflammasome (Keller et al., 2008; Willingham et al., 2009;
Lamkanfi et al., 2010). However, the underlying mechanism is
unknown.
Rather, an important difference between DAMPs and IL-1F
cytokines are the receptors. DAMPs bind to Pattern Recognition
Receptors (PRR) such as TLRs (Leadbetter et al., 2002; Park et al.,
2006; Yu et al., 2006), the most ancient membrane bound, and
intracellular receptors that detect microbial invasion and initiate
innate immune defenses (Kawai and Akira, 2010). These receptors
are promiscuous because of their tendency to associate with differ-
ent domains (Kawai and Akira, 2010), including domains present
in DAMPs. During evolution, the appearance of PRR and their
capacity to bind and be activated by some proteins released by
dying cells, have provided a second life to these proteins, which
became DAMPs.
IL-1F members have specific receptors belonging to the Toll-
IL-1 receptor (TIR) superfamily by virtue of their intracellular
signaling domain, shared with TLRs (O’Neill, 2008). These recep-
tors are endowed with three extracellular immunoglobulin (Ig)-
like repeats that bind IL-1F cytokines with high affinity. This
implies that, at variance with DAMPs, a relatively low concentra-
tion of a given IL-1F cytokine is adequate to trigger a physiological
response. The presence of specific receptor antagonists (i.e., IL-
1ra) and binding proteins (i.e., IL-18 binding protein), which
prevent cytokine-receptor interaction ensures a better control of
the inflammatory response than in the case of DAMPs (Dinarello,
2009).
IL-1F receptors evolved after PRR. Before, cytokines worked
as intracellular growth and repair molecules. Thus, in organisms
(such as starfish) expressing IL-1 like molecules (Beck and Habicht,
1986) and TLRs but not cytokine receptors, an IL-1 like molecule,
externalized by injured or stressed cells, was just diluted in the
water and lost. Only when Ig appeared and cytokine receptors
evolved, IL-1F members became able to work extracellularly as
soluble mediators.
The independent evolution of leaderless secretion aimed at
eliminating harmful intracellular proteins while maintaining cell
integrity and of Ig superfamily members that specifically bind
some leaderless secretory proteins, converged to assist in host
defense: proteins fought off cells because no longer useful, became
cytokines.
In conclusion, since TLR receptors are evolutionary more
ancient than IL-1F receptors, it is conceivable that DAMPs are
the first inflammatory mediators appeared along evolution. How-
ever, at variance with TLRs, IL-1F receptors are high affinity and
non-promiscuous receptors. Although some IL-1F cytokines are
passively released by dying cells, the production and activity of
other IL-1F members (IL-18, IL-1β) is strictly regulated. More-
over, increasing evidence indicates that also IL-1α and IL-33,
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classically considered as passively released, can be actively secreted
by stressed cells. Lack of promiscuity and control of cytokine
activity at several levels allows the generation of a complex net-
work of cytokines that ensures the correct development and
the positive outcome of inflammatory responses. Thus, although
DAMPs are indeed able to trigger and perpetrate inflammation,
the evolution of cytokines provided a strong impulse to innate
immunity.
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